Related Experiment Videos
Alternative induction and crossover schedules for methadyl acetate.
Archives of General Psychiatry
|February 1, 1984
Summary
This study found that various schedules for starting methadyl acetate treatment for heroin addiction are feasible. However, supplementing with methadone or methadyl acetate offered no significant advantage in treatment outcomes.
Area of Science:
- Addiction Medicine
- Pharmacology
- Clinical Research
Background:
- Opioid maintenance therapy is crucial for heroin addiction treatment.
- Methadyl acetate and methadone are key medications in opioid substitution treatment.
- Optimizing induction and transition schedules is essential for treatment efficacy.
Purpose of the Study:
- To evaluate the feasibility and effectiveness of different induction schedules for methadyl acetate maintenance.
- To assess crossover schedules for transitioning patients from methadone to methadyl acetate maintenance.
- To determine if supplementary methadone or methadyl acetate improves treatment outcomes.
Main Methods:
- Randomized controlled trials were conducted with street heroin addicts and patients on methadone maintenance.
- Three induction schedules for methadyl acetate were compared in the first study (n=255).
- Crossover schedules involving supplementary methadone or methadyl acetate were evaluated in the second study (n=310).
Main Results:
- All tested methadyl acetate induction schedules were found to be feasible.
- Supplementation with either methadone or methadyl acetate during induction showed no discernible advantage.
- A crossover schedule with supplementary methadyl acetate was unsuccessful; supplementary methadone offered no benefit.
Conclusions:
- Standard methadyl acetate induction schedules are viable options for treating heroin addiction.
- Supplementation strategies during methadyl acetate induction or crossover do not appear to enhance treatment effectiveness.
- Further research may be needed to refine transition protocols for opioid maintenance therapies.